Yumanity Therapeutics

BiotechnologySeries ABoston, USyumanity.com

Latest round

Series A

Last raised

Feb 2016

Total raised

$45M

Investors

6

About Yumanity Therapeutics

Yumanity Therapeutics, Inc.Founded in 2014, Yumanity Therapeutics, Inc. specializes in drug discovery for protein misfolding diseases. The company is headquartered in Boston, US. Richard Peters serves as the CEO.V.Yumanity offers innovative solutions in drug discovery, focusing on diseases related to protein misfolding, such as neurodegenerative disorders. Utilizing proprietary technology platforms, the company identifies and optimizes novel therapeutic candidates. The company is actively working on launching new therapeutic candidates that address critical needs in neurodegenerative disease treatment, with expectations for product introductions as they progress through clinical development phases.

Who invested in Yumanity Therapeutics

6 investors across 1 round

See all investors in Yumanity Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 8, 2016

    Amount

    $45M

    Investors

    Locked

Questions about Yumanity Therapeutics

Who invested in Yumanity Therapeutics?

Yumanity Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Yumanity Therapeutics raised?

Yumanity Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Yumanity Therapeutics last raise money?

Yumanity Therapeutics's most recent round on record is a Series A, in Feb 2016.

What does Yumanity Therapeutics do?

Yumanity Therapeutics is a biotechnology company.

Where is Yumanity Therapeutics headquartered?

Yumanity Therapeutics is headquartered in Boston, US.

Which VCs invest in companies like Yumanity Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Yumanity Therapeutics's stage. Their profiles are linked below.

Raising like Yumanity Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.